72.19.Z - Other research and experimental development on natural sciences and engineering
18.13.Z - Pre-press and pre-media services
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
64.92.Z - Other credit granting
72.11.Z - Research and experimental development on biotechnology
72.20.Z - Research and experimental development on social sciences and humanities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.19.Z - Photocopying, document preparation and other specialised office support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,6 | 3,7 | 0,6 | -84,5 |
EBITDA | 2,2 | 5,1 | 1,5 | -70,3 |
Short time liabilities | 0,2 | 0,3 | 0,1 | -64,1 |
Equity capital | 0,7 | 1,5 | 1,9 | 24,6 |
Operating profit (EBIT) | -1,3 | 3,9 | 0,6 | -85 |
Assets | 6,3 | 2,3 | 2 | -13,2 |
Net profit (loss) | -1,6 | 3,7 | 0,6 | -84,5 |
Cash | 0,2 | 0,7 | 0 | -97,9 |
Net income from sale | 0,9 | 0,9 | 2,4 | 177,8 |
Liabilities and provisions for liabilities | 5,6 | 0,8 | 0,1 | -85,5 |
Working assets | 1,8 | 1,3 | 1,9 | 49,7 |
Depreciation | 3,5 | 1,2 | 0,9 | -22,2 |
% | % | % | p.p. | |
Profitability of capital | -215,5 | 243,4 | 30,2 | -213,2 |
Equity capital to total assets | 11,7 | 65,7 | 94,3 | 28,6 |
Gross profit margin | -170,7 | 432,9 | 24,1 | -408,8 |
EBITDA Margin | 232,3 | 596,4 | 63,8 | -532,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 69 | 124 | 16 | -108 |
Current financial liquidity indicator | 0.5188795924186707 | 1.5808799266815186 | 17.607769012451172 | 16 |
Net dept to EBITDA | 0.887060821056366 | -0.12914258241653442 | -0.0025556841865181923 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane